Advertisement

Index by author

February 01, 1990; Volume 37,Issue 2

A

  1. Armah, B I

    1. Sodium channel comodification with full activator reveals veratridine reaction dynamics.
      G Wang, M Dugas, B I Armah and P Honerjäger
      Molecular Pharmacology February 1990, 37 (2) 144-148;

B

  1. Balzarini, J

    1. Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate.
      Z Hao, D A Cooney, D Farquhar, C F Perno, K Zhang, R Masood, Y Wilson, N R Hartman, J Balzarini and D G Johns
      Molecular Pharmacology February 1990, 37 (2) 157-163;

  2. Banet, D E

    1. Glucocorticoid regulation of polycyclic aromatic hydrocarbon induction of cytochrome P450IA1, glutathione S-transferases, and NAD(P)H:quinone oxidoreductase in cultured fetal rat hepatocytes.
      A J Sherratt, D E Banet and R A Prough
      Molecular Pharmacology February 1990, 37 (2) 198-205;

  3. Baron, J

    1. In situ localization and distribution of xenobiotic-activating enzymes and aryl hydrocarbon hydroxylase activity in lungs of untreated rats.
      J M Voigt, T T Kawabata, J P Burke, M V Martin, F P Guengerich and J Baron
      Molecular Pharmacology February 1990, 37 (2) 182-191;

  4. Barrington, W W

    1. Demonstration of both A1 and A2 adenosine receptors in DDT1 MF-2 smooth muscle cells.
      V Ramkumar, W W Barrington, K A Jacobson and G L Stiles
      Molecular Pharmacology February 1990, 37 (2) 149-156;

  5. Baudry, M

    1. N-Methyl-D-aspartate and quisqualate/DL-alpha-amino-3-hydroxy-5- methylisoxazole-4-propionic acid receptors: differential regulation by phospholipase C treatment.
      G Massicotte, M Kessler, G Lynch and M Baudry
      Molecular Pharmacology February 1990, 37 (2) 278-285;

  6. Berhane, K

    1. Inactivation of the genotoxic aldehyde acrolein by human glutathione transferases of classes alpha, mu, and pi.
      K Berhane and B Mannervik
      Molecular Pharmacology February 1990, 37 (2) 251-254;

  7. Berkovich, A

    1. A natural processing product of rat diazepam binding inhibitor, triakontatetraneuropeptide (diazepam binding inhibitor 17-50) contains an alpha-helix, which allows discrimination between benzodiazepine binding site subtypes.
      A Berkovich, P McPhie, M Campagnone, A Guidotti and P Hensley
      Molecular Pharmacology February 1990, 37 (2) 164-172;

  8. Blakley, R L

    1. Cytostatic effects of 2',3'-dideoxyribonucleosides on transformed human hemopoietic cell lines.
      R L Blakley, F C Harwood and K D Huff
      Molecular Pharmacology February 1990, 37 (2) 328-332;

  9. Bohmaker, K

    1. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
      E Meller, M Goldstein and K Bohmaker
      Molecular Pharmacology February 1990, 37 (2) 231-237;

  10. Brennan, S O

    1. Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations.
      U Kragh-Hansen, S O Brennan, M Galliano and O Sugita
      Molecular Pharmacology February 1990, 37 (2) 238-242;

  11. Burke, J P

    1. In situ localization and distribution of xenobiotic-activating enzymes and aryl hydrocarbon hydroxylase activity in lungs of untreated rats.
      J M Voigt, T T Kawabata, J P Burke, M V Martin, F P Guengerich and J Baron
      Molecular Pharmacology February 1990, 37 (2) 182-191;

C

  1. Campagnone, M

    1. A natural processing product of rat diazepam binding inhibitor, triakontatetraneuropeptide (diazepam binding inhibitor 17-50) contains an alpha-helix, which allows discrimination between benzodiazepine binding site subtypes.
      A Berkovich, P McPhie, M Campagnone, A Guidotti and P Hensley
      Molecular Pharmacology February 1990, 37 (2) 164-172;

  2. Cashman, J R

    1. Enantioselective S-oxygenation of para-methoxyphenyl-1,3-dithiolane by various tissue preparations: effect of estradiol.
      J R Cashman, L D Olsen, C E Lambert and M J Presas
      Molecular Pharmacology February 1990, 37 (2) 319-327;
    2. Enantioselective S-oxygenation of 2-aryl-1,3-dithiolanes by rabbit lung enzyme preparations.
      J R Cashman and D E Williams
      Molecular Pharmacology February 1990, 37 (2) 333-339;

  3. Cheung, A H

    1. Identification of allosteric antagonists of receptor-guanine nucleotide-binding protein interactions.
      R R Huang, R N Dehaven, A H Cheung, R E Diehl, R A Dixon and C D Strader
      Molecular Pharmacology February 1990, 37 (2) 304-310;

  4. Choi, O H

    1. Maitotoxin: effects on calcium channels, phosphoinositide breakdown, and arachidonate release in pheochromocytoma PC12 cells.
      O H Choi, W L Padgett, Y Nishizawa, F Gusovsky, T Yasumoto and J W Daly
      Molecular Pharmacology February 1990, 37 (2) 222-230;

  5. Cieslinski, L B

    1. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
      T J Torphy and L B Cieslinski
      Molecular Pharmacology February 1990, 37 (2) 206-214;

  6. Clements, D J

    1. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
      S P Cole, H F Downes, S E Mirski and D J Clements
      Molecular Pharmacology February 1990, 37 (2) 192-197;

  7. Cole, S P

    1. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
      S P Cole, H F Downes, S E Mirski and D J Clements
      Molecular Pharmacology February 1990, 37 (2) 192-197;

  8. Cooney, D A

    1. Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate.
      Z Hao, D A Cooney, D Farquhar, C F Perno, K Zhang, R Masood, Y Wilson, N R Hartman, J Balzarini and D G Johns
      Molecular Pharmacology February 1990, 37 (2) 157-163;

D

  1. Daly, J W

    1. Maitotoxin: effects on calcium channels, phosphoinositide breakdown, and arachidonate release in pheochromocytoma PC12 cells.
      O H Choi, W L Padgett, Y Nishizawa, F Gusovsky, T Yasumoto and J W Daly
      Molecular Pharmacology February 1990, 37 (2) 222-230;

  2. Dehaven, R N

    1. Identification of allosteric antagonists of receptor-guanine nucleotide-binding protein interactions.
      R R Huang, R N Dehaven, A H Cheung, R E Diehl, R A Dixon and C D Strader
      Molecular Pharmacology February 1990, 37 (2) 304-310;

  3. Diehl, R E

    1. Identification of allosteric antagonists of receptor-guanine nucleotide-binding protein interactions.
      R R Huang, R N Dehaven, A H Cheung, R E Diehl, R A Dixon and C D Strader
      Molecular Pharmacology February 1990, 37 (2) 304-310;

  4. Dixon, R A

    1. Identification of allosteric antagonists of receptor-guanine nucleotide-binding protein interactions.
      R R Huang, R N Dehaven, A H Cheung, R E Diehl, R A Dixon and C D Strader
      Molecular Pharmacology February 1990, 37 (2) 304-310;

  5. Downes, H F

    1. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
      S P Cole, H F Downes, S E Mirski and D J Clements
      Molecular Pharmacology February 1990, 37 (2) 192-197;

  6. Dugas, M

    1. Sodium channel comodification with full activator reveals veratridine reaction dynamics.
      G Wang, M Dugas, B I Armah and P Honerjäger
      Molecular Pharmacology February 1990, 37 (2) 144-148;

E

  1. Eyer, P

    1. Aniline-, phenylhydroxylamine-, nitrosobenzene-, and nitrobenzene-induced hemoglobin thiyl free radical formation in vivo and in vitro.
      K R Maples, P Eyer and R P Mason
      Molecular Pharmacology February 1990, 37 (2) 311-318;

F

  1. Farquhar, D

    1. Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate.
      Z Hao, D A Cooney, D Farquhar, C F Perno, K Zhang, R Masood, Y Wilson, N R Hartman, J Balzarini and D G Johns
      Molecular Pharmacology February 1990, 37 (2) 157-163;

  2. Froimowitz, M

    1. Requirements for the activation of protein kinase C: comparison of the molecular geometries of phorbol and diacylglycerol.
      U Leli, G Hauser and M Froimowitz
      Molecular Pharmacology February 1990, 37 (2) 286-295;

G

  1. Galliano, M

    1. Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations.
      U Kragh-Hansen, S O Brennan, M Galliano and O Sugita
      Molecular Pharmacology February 1990, 37 (2) 238-242;

  2. Goldstein, M

    1. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
      E Meller, M Goldstein and K Bohmaker
      Molecular Pharmacology February 1990, 37 (2) 231-237;

  3. Gorski, J

    1. Regulation of prolactin gene transcription in vivo: interactions between estrogen, pimozide, and alpha-ergocryptine.
      J D Shull and J Gorski
      Molecular Pharmacology February 1990, 37 (2) 215-221;

  4. Guengerich, F P

    1. In situ localization and distribution of xenobiotic-activating enzymes and aryl hydrocarbon hydroxylase activity in lungs of untreated rats.
      J M Voigt, T T Kawabata, J P Burke, M V Martin, F P Guengerich and J Baron
      Molecular Pharmacology February 1990, 37 (2) 182-191;

  5. Guidotti, A

    1. A natural processing product of rat diazepam binding inhibitor, triakontatetraneuropeptide (diazepam binding inhibitor 17-50) contains an alpha-helix, which allows discrimination between benzodiazepine binding site subtypes.
      A Berkovich, P McPhie, M Campagnone, A Guidotti and P Hensley
      Molecular Pharmacology February 1990, 37 (2) 164-172;

  6. Gusovsky, F

    1. Maitotoxin: effects on calcium channels, phosphoinositide breakdown, and arachidonate release in pheochromocytoma PC12 cells.
      O H Choi, W L Padgett, Y Nishizawa, F Gusovsky, T Yasumoto and J W Daly
      Molecular Pharmacology February 1990, 37 (2) 222-230;

  7. Guyda, H J

    1. Benzo(a)pyrene inhibits epidermal growth factor binding and receptor autophosphorylation in human placental cell cultures.
      H J Guyda, L Mathieu, W Lai, D Manchester, S L Wang, S Ogilvie and K T Shiverick
      Molecular Pharmacology February 1990, 37 (2) 137-143;

H

  1. Hao, Z

    1. Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate.
      Z Hao, D A Cooney, D Farquhar, C F Perno, K Zhang, R Masood, Y Wilson, N R Hartman, J Balzarini and D G Johns
      Molecular Pharmacology February 1990, 37 (2) 157-163;

  2. Hartman, N R

    1. Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate.
      Z Hao, D A Cooney, D Farquhar, C F Perno, K Zhang, R Masood, Y Wilson, N R Hartman, J Balzarini and D G Johns
      Molecular Pharmacology February 1990, 37 (2) 157-163;

  3. Harwood, F C

    1. Cytostatic effects of 2',3'-dideoxyribonucleosides on transformed human hemopoietic cell lines.
      R L Blakley, F C Harwood and K D Huff
      Molecular Pharmacology February 1990, 37 (2) 328-332;

  4. Hauser, G

    1. Requirements for the activation of protein kinase C: comparison of the molecular geometries of phorbol and diacylglycerol.
      U Leli, G Hauser and M Froimowitz
      Molecular Pharmacology February 1990, 37 (2) 286-295;

  5. Hensley, P

    1. A natural processing product of rat diazepam binding inhibitor, triakontatetraneuropeptide (diazepam binding inhibitor 17-50) contains an alpha-helix, which allows discrimination between benzodiazepine binding site subtypes.
      A Berkovich, P McPhie, M Campagnone, A Guidotti and P Hensley
      Molecular Pharmacology February 1990, 37 (2) 164-172;

  6. Honerjäger, P

    1. Sodium channel comodification with full activator reveals veratridine reaction dynamics.
      G Wang, M Dugas, B I Armah and P Honerjäger
      Molecular Pharmacology February 1990, 37 (2) 144-148;

  7. Huang, R R

    1. Identification of allosteric antagonists of receptor-guanine nucleotide-binding protein interactions.
      R R Huang, R N Dehaven, A H Cheung, R E Diehl, R A Dixon and C D Strader
      Molecular Pharmacology February 1990, 37 (2) 304-310;

  8. Huff, K D

    1. Cytostatic effects of 2',3'-dideoxyribonucleosides on transformed human hemopoietic cell lines.
      R L Blakley, F C Harwood and K D Huff
      Molecular Pharmacology February 1990, 37 (2) 328-332;

  9. Hunchak, K

    1. Effect of platelet activation on the agglutination of platelets by von Willebrand factor.
      D C Mills, K Hunchak, D W Karl and E P Kirby
      Molecular Pharmacology February 1990, 37 (2) 271-277;

J

  1. Jacobson, K A

    1. Demonstration of both A1 and A2 adenosine receptors in DDT1 MF-2 smooth muscle cells.
      V Ramkumar, W W Barrington, K A Jacobson and G L Stiles
      Molecular Pharmacology February 1990, 37 (2) 149-156;

  2. Johns, D G

    1. Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate.
      Z Hao, D A Cooney, D Farquhar, C F Perno, K Zhang, R Masood, Y Wilson, N R Hartman, J Balzarini and D G Johns
      Molecular Pharmacology February 1990, 37 (2) 157-163;

  3. Johnson, R A

    1. Protein kinase C activators sensitize cyclic AMP accumulation by intact 1321N1 human astrocytoma cells.
      R A Johnson and M L Toews
      Molecular Pharmacology February 1990, 37 (2) 296-303;

K

  1. Karl, D W

    1. Effect of platelet activation on the agglutination of platelets by von Willebrand factor.
      D C Mills, K Hunchak, D W Karl and E P Kirby
      Molecular Pharmacology February 1990, 37 (2) 271-277;

  2. Kawabata, T T

    1. In situ localization and distribution of xenobiotic-activating enzymes and aryl hydrocarbon hydroxylase activity in lungs of untreated rats.
      J M Voigt, T T Kawabata, J P Burke, M V Martin, F P Guengerich and J Baron
      Molecular Pharmacology February 1990, 37 (2) 182-191;

  3. Kessler, M

    1. N-Methyl-D-aspartate and quisqualate/DL-alpha-amino-3-hydroxy-5- methylisoxazole-4-propionic acid receptors: differential regulation by phospholipase C treatment.
      G Massicotte, M Kessler, G Lynch and M Baudry
      Molecular Pharmacology February 1990, 37 (2) 278-285;

  4. Kirby, E P

    1. Effect of platelet activation on the agglutination of platelets by von Willebrand factor.
      D C Mills, K Hunchak, D W Karl and E P Kirby
      Molecular Pharmacology February 1990, 37 (2) 271-277;

  5. Kragh-Hansen, U

    1. Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations.
      U Kragh-Hansen, S O Brennan, M Galliano and O Sugita
      Molecular Pharmacology February 1990, 37 (2) 238-242;

L

  1. Lai, W

    1. Benzo(a)pyrene inhibits epidermal growth factor binding and receptor autophosphorylation in human placental cell cultures.
      H J Guyda, L Mathieu, W Lai, D Manchester, S L Wang, S Ogilvie and K T Shiverick
      Molecular Pharmacology February 1990, 37 (2) 137-143;

  2. Lambert, C E

    1. Enantioselective S-oxygenation of para-methoxyphenyl-1,3-dithiolane by various tissue preparations: effect of estradiol.
      J R Cashman, L D Olsen, C E Lambert and M J Presas
      Molecular Pharmacology February 1990, 37 (2) 319-327;

  3. Leli, U

    1. Requirements for the activation of protein kinase C: comparison of the molecular geometries of phorbol and diacylglycerol.
      U Leli, G Hauser and M Froimowitz
      Molecular Pharmacology February 1990, 37 (2) 286-295;

  4. Lemaire, S

    1. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
      B J Murphy, C A Rogers, R K Sunahara, S Lemaire and B S Tuana
      Molecular Pharmacology February 1990, 37 (2) 173-181;

  5. Li, S X

    1. Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor.
      L Y Liu-Chen, S X Li and R J Tallarida
      Molecular Pharmacology February 1990, 37 (2) 243-250;

  6. Liu-Chen, L Y

    1. Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor.
      L Y Liu-Chen, S X Li and R J Tallarida
      Molecular Pharmacology February 1990, 37 (2) 243-250;

  7. Lynch, G

    1. N-Methyl-D-aspartate and quisqualate/DL-alpha-amino-3-hydroxy-5- methylisoxazole-4-propionic acid receptors: differential regulation by phospholipase C treatment.
      G Massicotte, M Kessler, G Lynch and M Baudry
      Molecular Pharmacology February 1990, 37 (2) 278-285;

M

  1. Manchester, D

    1. Benzo(a)pyrene inhibits epidermal growth factor binding and receptor autophosphorylation in human placental cell cultures.
      H J Guyda, L Mathieu, W Lai, D Manchester, S L Wang, S Ogilvie and K T Shiverick
      Molecular Pharmacology February 1990, 37 (2) 137-143;

  2. Mannervik, B

    1. Inactivation of the genotoxic aldehyde acrolein by human glutathione transferases of classes alpha, mu, and pi.
      K Berhane and B Mannervik
      Molecular Pharmacology February 1990, 37 (2) 251-254;

  3. Maples, K R

    1. Aniline-, phenylhydroxylamine-, nitrosobenzene-, and nitrobenzene-induced hemoglobin thiyl free radical formation in vivo and in vitro.
      K R Maples, P Eyer and R P Mason
      Molecular Pharmacology February 1990, 37 (2) 311-318;

  4. Martin, M V

    1. In situ localization and distribution of xenobiotic-activating enzymes and aryl hydrocarbon hydroxylase activity in lungs of untreated rats.
      J M Voigt, T T Kawabata, J P Burke, M V Martin, F P Guengerich and J Baron
      Molecular Pharmacology February 1990, 37 (2) 182-191;

  5. Mason, R P

    1. Aniline-, phenylhydroxylamine-, nitrosobenzene-, and nitrobenzene-induced hemoglobin thiyl free radical formation in vivo and in vitro.
      K R Maples, P Eyer and R P Mason
      Molecular Pharmacology February 1990, 37 (2) 311-318;

  6. Masood, R

    1. Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate.
      Z Hao, D A Cooney, D Farquhar, C F Perno, K Zhang, R Masood, Y Wilson, N R Hartman, J Balzarini and D G Johns
      Molecular Pharmacology February 1990, 37 (2) 157-163;

  7. Massicotte, G

    1. N-Methyl-D-aspartate and quisqualate/DL-alpha-amino-3-hydroxy-5- methylisoxazole-4-propionic acid receptors: differential regulation by phospholipase C treatment.
      G Massicotte, M Kessler, G Lynch and M Baudry
      Molecular Pharmacology February 1990, 37 (2) 278-285;

  8. Mathieu, L

    1. Benzo(a)pyrene inhibits epidermal growth factor binding and receptor autophosphorylation in human placental cell cultures.
      H J Guyda, L Mathieu, W Lai, D Manchester, S L Wang, S Ogilvie and K T Shiverick
      Molecular Pharmacology February 1990, 37 (2) 137-143;

  9. McPhie, P

    1. A natural processing product of rat diazepam binding inhibitor, triakontatetraneuropeptide (diazepam binding inhibitor 17-50) contains an alpha-helix, which allows discrimination between benzodiazepine binding site subtypes.
      A Berkovich, P McPhie, M Campagnone, A Guidotti and P Hensley
      Molecular Pharmacology February 1990, 37 (2) 164-172;

  10. Meller, E

    1. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
      E Meller, M Goldstein and K Bohmaker
      Molecular Pharmacology February 1990, 37 (2) 231-237;

  11. Mills, D C

    1. Effect of platelet activation on the agglutination of platelets by von Willebrand factor.
      D C Mills, K Hunchak, D W Karl and E P Kirby
      Molecular Pharmacology February 1990, 37 (2) 271-277;

  12. Mirski, S E

    1. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
      S P Cole, H F Downes, S E Mirski and D J Clements
      Molecular Pharmacology February 1990, 37 (2) 192-197;

  13. Morrow, A L

    1. Characterization of steroid interactions with gamma-aminobutyric acid receptor-gated chloride ion channels: evidence for multiple steroid recognition sites.
      A L Morrow, J R Pace, R H Purdy and S M Paul
      Molecular Pharmacology February 1990, 37 (2) 263-270;

  14. Murphy, B J

    1. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
      B J Murphy, C A Rogers, R K Sunahara, S Lemaire and B S Tuana
      Molecular Pharmacology February 1990, 37 (2) 173-181;

N

  1. Nishizawa, Y

    1. Maitotoxin: effects on calcium channels, phosphoinositide breakdown, and arachidonate release in pheochromocytoma PC12 cells.
      O H Choi, W L Padgett, Y Nishizawa, F Gusovsky, T Yasumoto and J W Daly
      Molecular Pharmacology February 1990, 37 (2) 222-230;

O

  1. Ogilvie, S

    1. Benzo(a)pyrene inhibits epidermal growth factor binding and receptor autophosphorylation in human placental cell cultures.
      H J Guyda, L Mathieu, W Lai, D Manchester, S L Wang, S Ogilvie and K T Shiverick
      Molecular Pharmacology February 1990, 37 (2) 137-143;

  2. Olsen, L D

    1. Enantioselective S-oxygenation of para-methoxyphenyl-1,3-dithiolane by various tissue preparations: effect of estradiol.
      J R Cashman, L D Olsen, C E Lambert and M J Presas
      Molecular Pharmacology February 1990, 37 (2) 319-327;

P

  1. Pace, J R

    1. Characterization of steroid interactions with gamma-aminobutyric acid receptor-gated chloride ion channels: evidence for multiple steroid recognition sites.
      A L Morrow, J R Pace, R H Purdy and S M Paul
      Molecular Pharmacology February 1990, 37 (2) 263-270;

  2. Padgett, W L

    1. Maitotoxin: effects on calcium channels, phosphoinositide breakdown, and arachidonate release in pheochromocytoma PC12 cells.
      O H Choi, W L Padgett, Y Nishizawa, F Gusovsky, T Yasumoto and J W Daly
      Molecular Pharmacology February 1990, 37 (2) 222-230;

  3. Paul, S M

    1. Characterization of steroid interactions with gamma-aminobutyric acid receptor-gated chloride ion channels: evidence for multiple steroid recognition sites.
      A L Morrow, J R Pace, R H Purdy and S M Paul
      Molecular Pharmacology February 1990, 37 (2) 263-270;

  4. Perno, C F

    1. Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate.
      Z Hao, D A Cooney, D Farquhar, C F Perno, K Zhang, R Masood, Y Wilson, N R Hartman, J Balzarini and D G Johns
      Molecular Pharmacology February 1990, 37 (2) 157-163;

  5. Presas, M J

    1. Enantioselective S-oxygenation of para-methoxyphenyl-1,3-dithiolane by various tissue preparations: effect of estradiol.
      J R Cashman, L D Olsen, C E Lambert and M J Presas
      Molecular Pharmacology February 1990, 37 (2) 319-327;

  6. Prough, R A

    1. Glucocorticoid regulation of polycyclic aromatic hydrocarbon induction of cytochrome P450IA1, glutathione S-transferases, and NAD(P)H:quinone oxidoreductase in cultured fetal rat hepatocytes.
      A J Sherratt, D E Banet and R A Prough
      Molecular Pharmacology February 1990, 37 (2) 198-205;

  7. Purdy, R H

    1. Characterization of steroid interactions with gamma-aminobutyric acid receptor-gated chloride ion channels: evidence for multiple steroid recognition sites.
      A L Morrow, J R Pace, R H Purdy and S M Paul
      Molecular Pharmacology February 1990, 37 (2) 263-270;

R

  1. Ramkumar, V

    1. Demonstration of both A1 and A2 adenosine receptors in DDT1 MF-2 smooth muscle cells.
      V Ramkumar, W W Barrington, K A Jacobson and G L Stiles
      Molecular Pharmacology February 1990, 37 (2) 149-156;

  2. Reasor, M J

    1. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells.
      D J Thomas, A Sadler, V V Subrahmanyam, D Siegel, M J Reasor, D Wierda and D Ross
      Molecular Pharmacology February 1990, 37 (2) 255-262;

  3. Rogers, C A

    1. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
      B J Murphy, C A Rogers, R K Sunahara, S Lemaire and B S Tuana
      Molecular Pharmacology February 1990, 37 (2) 173-181;

  4. Ross, D

    1. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells.
      D J Thomas, A Sadler, V V Subrahmanyam, D Siegel, M J Reasor, D Wierda and D Ross
      Molecular Pharmacology February 1990, 37 (2) 255-262;

S

  1. Sadler, A

    1. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells.
      D J Thomas, A Sadler, V V Subrahmanyam, D Siegel, M J Reasor, D Wierda and D Ross
      Molecular Pharmacology February 1990, 37 (2) 255-262;

  2. Sherratt, A J

    1. Glucocorticoid regulation of polycyclic aromatic hydrocarbon induction of cytochrome P450IA1, glutathione S-transferases, and NAD(P)H:quinone oxidoreductase in cultured fetal rat hepatocytes.
      A J Sherratt, D E Banet and R A Prough
      Molecular Pharmacology February 1990, 37 (2) 198-205;

  3. Shiverick, K T

    1. Benzo(a)pyrene inhibits epidermal growth factor binding and receptor autophosphorylation in human placental cell cultures.
      H J Guyda, L Mathieu, W Lai, D Manchester, S L Wang, S Ogilvie and K T Shiverick
      Molecular Pharmacology February 1990, 37 (2) 137-143;

  4. Shull, J D

    1. Regulation of prolactin gene transcription in vivo: interactions between estrogen, pimozide, and alpha-ergocryptine.
      J D Shull and J Gorski
      Molecular Pharmacology February 1990, 37 (2) 215-221;

  5. Siegel, D

    1. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells.
      D J Thomas, A Sadler, V V Subrahmanyam, D Siegel, M J Reasor, D Wierda and D Ross
      Molecular Pharmacology February 1990, 37 (2) 255-262;

  6. Stiles, G L

    1. Demonstration of both A1 and A2 adenosine receptors in DDT1 MF-2 smooth muscle cells.
      V Ramkumar, W W Barrington, K A Jacobson and G L Stiles
      Molecular Pharmacology February 1990, 37 (2) 149-156;

  7. Strader, C D

    1. Identification of allosteric antagonists of receptor-guanine nucleotide-binding protein interactions.
      R R Huang, R N Dehaven, A H Cheung, R E Diehl, R A Dixon and C D Strader
      Molecular Pharmacology February 1990, 37 (2) 304-310;

  8. Subrahmanyam, V V

    1. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells.
      D J Thomas, A Sadler, V V Subrahmanyam, D Siegel, M J Reasor, D Wierda and D Ross
      Molecular Pharmacology February 1990, 37 (2) 255-262;

  9. Sugita, O

    1. Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations.
      U Kragh-Hansen, S O Brennan, M Galliano and O Sugita
      Molecular Pharmacology February 1990, 37 (2) 238-242;

  10. Sunahara, R K

    1. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
      B J Murphy, C A Rogers, R K Sunahara, S Lemaire and B S Tuana
      Molecular Pharmacology February 1990, 37 (2) 173-181;

T

  1. Tallarida, R J

    1. Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor.
      L Y Liu-Chen, S X Li and R J Tallarida
      Molecular Pharmacology February 1990, 37 (2) 243-250;

  2. Thomas, D J

    1. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells.
      D J Thomas, A Sadler, V V Subrahmanyam, D Siegel, M J Reasor, D Wierda and D Ross
      Molecular Pharmacology February 1990, 37 (2) 255-262;

  3. Toews, M L

    1. Protein kinase C activators sensitize cyclic AMP accumulation by intact 1321N1 human astrocytoma cells.
      R A Johnson and M L Toews
      Molecular Pharmacology February 1990, 37 (2) 296-303;

  4. Torphy, T J

    1. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
      T J Torphy and L B Cieslinski
      Molecular Pharmacology February 1990, 37 (2) 206-214;

  5. Tuana, B S

    1. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
      B J Murphy, C A Rogers, R K Sunahara, S Lemaire and B S Tuana
      Molecular Pharmacology February 1990, 37 (2) 173-181;

V

  1. Voigt, J M

    1. In situ localization and distribution of xenobiotic-activating enzymes and aryl hydrocarbon hydroxylase activity in lungs of untreated rats.
      J M Voigt, T T Kawabata, J P Burke, M V Martin, F P Guengerich and J Baron
      Molecular Pharmacology February 1990, 37 (2) 182-191;

W

  1. Wang, G

    1. Sodium channel comodification with full activator reveals veratridine reaction dynamics.
      G Wang, M Dugas, B I Armah and P Honerjäger
      Molecular Pharmacology February 1990, 37 (2) 144-148;

  2. Wang, S L

    1. Benzo(a)pyrene inhibits epidermal growth factor binding and receptor autophosphorylation in human placental cell cultures.
      H J Guyda, L Mathieu, W Lai, D Manchester, S L Wang, S Ogilvie and K T Shiverick
      Molecular Pharmacology February 1990, 37 (2) 137-143;

  3. Wierda, D

    1. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells.
      D J Thomas, A Sadler, V V Subrahmanyam, D Siegel, M J Reasor, D Wierda and D Ross
      Molecular Pharmacology February 1990, 37 (2) 255-262;

  4. Williams, D E

    1. Enantioselective S-oxygenation of 2-aryl-1,3-dithiolanes by rabbit lung enzyme preparations.
      J R Cashman and D E Williams
      Molecular Pharmacology February 1990, 37 (2) 333-339;

  5. Wilson, Y

    1. Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate.
      Z Hao, D A Cooney, D Farquhar, C F Perno, K Zhang, R Masood, Y Wilson, N R Hartman, J Balzarini and D G Johns
      Molecular Pharmacology February 1990, 37 (2) 157-163;

Y

  1. Yasumoto, T

    1. Maitotoxin: effects on calcium channels, phosphoinositide breakdown, and arachidonate release in pheochromocytoma PC12 cells.
      O H Choi, W L Padgett, Y Nishizawa, F Gusovsky, T Yasumoto and J W Daly
      Molecular Pharmacology February 1990, 37 (2) 222-230;

Z

  1. Zhang, K

    1. Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate.
      Z Hao, D A Cooney, D Farquhar, C F Perno, K Zhang, R Masood, Y Wilson, N R Hartman, J Balzarini and D G Johns
      Molecular Pharmacology February 1990, 37 (2) 157-163;
Back to top

In this issue